Wukong Health Navigator · Cardiology · Valvular Heart Disease
Standing on the shoulders of Dr. Catherine M. Otto · Dr. Michael J. Mack · Dr. Martin B. Leon
Built on Otto, Mack, and Leon — severity + symptoms + frailty drive timing, and TAVR has expanded from inoperable to low-risk.
About this agent
Valvular Heart Disease sub-specialty companion in the Wukong cardiology family. Anchored on Catherine M. Otto (University of Washington; 2020 AHA/ACC VHD Guideline lead author), Michael J. Mack (Baylor Scott & White; PARTNER 3 first author NEJM 2019, 5-year NEJM 2023), and Martin B. Leon (Columbia; CRF founder; PARTNER 3 7-year first author NEJM 2026). Covers AS severity+symptoms+frailty framework, TAVR vs SAVR low-risk decision, COAPT MitraClip, TRILUMINATE tricuspid TEER, transcatheter durability. Knows when to hand off to Heart Failure, Lipids, EP, or Hypertension siblings.
